136 related articles for article (PubMed ID: 11432788)
1. Effects of troponin T mutations in familial hypertrophic cardiomyopathy on regulatory functions of other troponin subunits.
Takahashi-Yanaga F; Ohtsuki I; Morimoto S
J Biochem; 2001 Jul; 130(1):127-31. PubMed ID: 11432788
[TBL] [Abstract][Full Text] [Related]
2. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
Takahashi-Yanaga F; Morimoto S; Harada K; Minakami R; Shiraishi F; Ohta M; Lu QW; Sasaguri T; Ohtsuki I
J Mol Cell Cardiol; 2001 Dec; 33(12):2095-107. PubMed ID: 11735257
[TBL] [Abstract][Full Text] [Related]
3. Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C.
Zot HG; Hasbun JE; Michell CA; Landim-Vieira M; Pinto JR
Arch Biochem Biophys; 2016 Jul; 601():97-104. PubMed ID: 26976709
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of the deletion mutation deltaGlu160 in human cardiac troponin T.
Harada K; Takahashi-Yanaga F; Minakami R; Morimoto S; Ohtsuki I
J Biochem; 2000 Feb; 127(2):263-8. PubMed ID: 10731693
[TBL] [Abstract][Full Text] [Related]
5. Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.
Sparrow AJ; Sievert K; Patel S; Chang YF; Broyles CN; Brook FA; Watkins H; Geeves MA; Redwood CS; Robinson P; Daniels MJ
Circ Res; 2019 Apr; 124(8):1228-1239. PubMed ID: 30732532
[TBL] [Abstract][Full Text] [Related]
6. Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy.
Yanaga F; Morimoto S; Ohtsuki I
J Biol Chem; 1999 Mar; 274(13):8806-12. PubMed ID: 10085122
[TBL] [Abstract][Full Text] [Related]
7. Troponin C Mutations Partially Stabilize the Active State of Regulated Actin and Fully Stabilize the Active State When Paired with Δ14 TnT.
Baxley T; Johnson D; Pinto JR; Chalovich JM
Biochemistry; 2017 Jun; 56(23):2928-2937. PubMed ID: 28530094
[TBL] [Abstract][Full Text] [Related]
8. Troponins, intrinsic disorder, and cardiomyopathy.
Na I; Kong MJ; Straight S; Pinto JR; Uversky VN
Biol Chem; 2016 Aug; 397(8):731-51. PubMed ID: 27074551
[TBL] [Abstract][Full Text] [Related]
9. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
Gomes AV; Harada K; Potter JD
J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
[TBL] [Abstract][Full Text] [Related]
10. Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy.
Nakaura H; Morimoto S; Yanaga F; Nakata M; Nishi H; Imaizumi T; Ohtsuki I
Am J Physiol; 1999 Aug; 277(2):C225-32. PubMed ID: 10444398
[TBL] [Abstract][Full Text] [Related]
11. Effects of missense mutations Phe110Ile and Glu244Asp in human cardiac troponin T on force generation in skinned cardiac muscle fibers.
Nakaura H; Yanaga F; Ohtsuki I; Morimoto S
J Biochem; 1999 Sep; 126(3):457-60. PubMed ID: 10467159
[TBL] [Abstract][Full Text] [Related]
12. Ca(2+)-regulatory function of the inhibitory peptide region of cardiac troponin I is aided by the C-terminus of cardiac troponin T: Effects of familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT R278C, alone and in combination, on filament sliding.
Brunet NM; Chase PB; Mihajlović G; Schoffstall B
Arch Biochem Biophys; 2014 Jun; 552-553():11-20. PubMed ID: 24418317
[TBL] [Abstract][Full Text] [Related]
13. Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy.
Morimoto S; Yanaga F; Minakami R; Ohtsuki I
Am J Physiol; 1998 Jul; 275(1):C200-7. PubMed ID: 9688851
[TBL] [Abstract][Full Text] [Related]
14. Effect of Arg145Gly mutation in human cardiac troponin I on the ATPase activity of cardiac myofibrils.
Takahashi-Yanaga F; Morimoto S; Ohtsuki I
J Biochem; 2000 Mar; 127(3):355-7. PubMed ID: 10731705
[TBL] [Abstract][Full Text] [Related]
15. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility.
Marian AJ; Zhao G; Seta Y; Roberts R; Yu QT
Circ Res; 1997 Jul; 81(1):76-85. PubMed ID: 9201030
[TBL] [Abstract][Full Text] [Related]
16. Functional consequences of a carboxyl terminal missense mutation Arg278Cys in human cardiac troponin T.
Morimoto S; Nakaura H; Yanaga F; Ohtsuki I
Biochem Biophys Res Commun; 1999 Jul; 261(1):79-82. PubMed ID: 10405326
[TBL] [Abstract][Full Text] [Related]
17. A recombinant monocysteine mutant (Ser to Cys-155) of fast skeletal troponin T: identification by cross-linking of a domain involved in a physiologically relevant interaction with troponins C and I.
Jha PK; Sarkar S
Biochemistry; 1998 Sep; 37(35):12253-60. PubMed ID: 9724539
[TBL] [Abstract][Full Text] [Related]
18. Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation.
Messer AE; Bayliss CR; El-Mezgueldi M; Redwood CS; Ward DG; Leung MC; Papadaki M; Dos Remedios C; Marston SB
Arch Biochem Biophys; 2016 Jul; 601():113-20. PubMed ID: 27036851
[TBL] [Abstract][Full Text] [Related]
19. Characterization of troponin T dilated cardiomyopathy mutations in the fetal troponin isoform.
Venkatraman G; Gomes AV; Kerrick WG; Potter JD
J Biol Chem; 2005 May; 280(18):17584-92. PubMed ID: 15623536
[TBL] [Abstract][Full Text] [Related]
20. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
